BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 15925846)

  • 1. Refractory coeliac disease.
    Daum S; Cellier C; Mulder CJ
    Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):413-24. PubMed ID: 15925846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma.
    Mulder CJ; Wahab PJ; Moshaver B; Meijer JW
    Scand J Gastroenterol Suppl; 2000; (232):32-7. PubMed ID: 11232488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
    Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
    Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of complicated celiac disease.
    Al-toma A; Verbeek WH; Mulder CJ
    Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring nonresponsive patients who have celiac disease.
    Krauss N; Schuppan D
    Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased circulating iNKT cell numbers in refractory coeliac disease.
    Bernardo D; van Hoogstraten IM; Verbeek WH; Peña AS; Mearin ML; Arranz E; Garrote JA; Scheper RJ; Schreurs MW; Bontkes HJ; Mulder CJ; von Blomberg BM
    Clin Immunol; 2008 Feb; 126(2):172-9. PubMed ID: 17974485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in refractory coeliac disease: a review.
    Ho-Yen C; Chang F; van der Walt J; Mitchell T; Ciclitira P
    Histopathology; 2009 Jun; 54(7):783-95. PubMed ID: 18700844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype.
    de Mascarel A; Belleannée G; Stanislas S; Merlio C; Parrens M; Laharie D; Dubus P; Merlio JP
    Am J Surg Pathol; 2008 May; 32(5):744-51. PubMed ID: 18360280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the management of refractory coeliac disease.
    Al-Toma A; Verbeek WH; Mulder CJ
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):57-63. PubMed ID: 17410290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
    Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
    Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of small intestinal intraepithelial gamma/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease.
    Verbeek WH; von Blomberg BM; Scholten PE; Kuik DJ; Mulder CJ; Schreurs MW
    Am J Gastroenterol; 2008 Dec; 103(12):3152-8. PubMed ID: 19086962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience.
    Nasr I; Nasr I; Beyers C; Chang F; Donnelly S; Ciclitira PJ
    Nutrients; 2015 Dec; 7(12):9896-907. PubMed ID: 26633478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
    Verbeek WH; Goerres MS; von Blomberg BM; Oudejans JJ; Scholten PE; Hadithi M; Al-Toma A; Schreurs MW; Mulder CJ
    Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cladribine therapy in refractory celiac disease with aberrant T cells.
    Al-Toma A; Goerres MS; Meijer JW; von Blomberg BM; Wahab PJ; Kerckhaert JA; Mulder CJ
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1322-7; quiz 1300. PubMed ID: 16979946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant complications of coeliac disease.
    Brousse N; Meijer JW
    Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):401-12. PubMed ID: 15925845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enteropathy-associated T-cell lymphoma. Manifestation as diet-refractory coeliac disease and ulcerating jejunitis].
    Bächle T; Rühl U; Ott G; Walker S
    Dtsch Med Wochenschr; 2001 Dec; 126(51-52):1460-3. PubMed ID: 11753737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group.
    Cellier C; Delabesse E; Helmer C; Patey N; Matuchansky C; Jabri B; Macintyre E; Cerf-Bensussan N; Brousse N
    Lancet; 2000 Jul; 356(9225):203-8. PubMed ID: 10963198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
    Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capsule endoscopy in refractory celiac disease.
    Daum S; Wahnschaffe U; Glasenapp R; Borchert M; Ullrich R; Zeitz M; Faiss S
    Endoscopy; 2007 May; 39(5):455-8. PubMed ID: 17516353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue.
    Daum S; Weiss D; Hummel M; Ullrich R; Heise W; Stein H; Riecken EO; Foss HD;
    Gut; 2001 Dec; 49(6):804-12. PubMed ID: 11709515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.